These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31271889)

  • 1. SOX4: Epigenetic regulation and role in tumorigenesis.
    Hanieh H; Ahmed EA; Vishnubalaji R; Alajez NM
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):91-104. PubMed ID: 31271889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?
    Lourenço AR; Coffer PJ
    Trends Cancer; 2017 Aug; 3(8):571-582. PubMed ID: 28780934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?
    Vervoort SJ; van Boxtel R; Coffer PJ
    Oncogene; 2013 Jul; 32(29):3397-409. PubMed ID: 23246969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer.
    Wu X; Xin Z; Zou Z; Lu C; Yu Z; Feng S; Pan P; Hao G; Dong Y; Yang Y
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):114-121. PubMed ID: 31199986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.
    Ruan H; Yang H; Wei H; Xiao W; Lou N; Qiu B; Xu G; Song Z; Xiao H; Liu L; Zhou Y; Hu W; Chen K; Chen X; Zhang X
    Int J Oncol; 2017 Jul; 51(1):336-346. PubMed ID: 28534986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA BG981369 Inhibits Cell Proliferation, Migration, and Invasion, and Promotes Cell Apoptosis by SRY-Related High-Mobility Group Box 4 (SOX4) Signaling Pathway in Human Gastric Cancer.
    Dong X; Chen R; Lin H; Lin T; Pan S
    Med Sci Monit; 2018 Feb; 24():718-726. PubMed ID: 29398692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
    Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression.
    Liao C; Long Z; Zhang X; Cheng J; Qi F; Wu S; Huang T
    Int J Biol Sci; 2020; 16(1):1-11. PubMed ID: 31892841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
    Liu Y; Zeng S; Jiang X; Lai D; Su Z
    Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
    Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
    Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
    Zhao G; Yin Y; Zhao B
    J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
    Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
    Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.
    Tiwari N; Tiwari VK; Waldmeier L; Balwierz PJ; Arnold P; Pachkov M; Meyer-Schaller N; Schübeler D; van Nimwegen E; Christofori G
    Cancer Cell; 2013 Jun; 23(6):768-83. PubMed ID: 23764001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop.
    Li D; He C; Wang J; Wang Y; Bu J; Kong X; Sun D
    Oncol Res; 2018 Apr; 26(3):385-400. PubMed ID: 28653608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.
    Wang CY; Hua L; Sun J; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(11):14013-20. PubMed ID: 26823713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.
    Jafarnejad SM; Ardekani GS; Ghaffari M; Li G
    Cell Mol Life Sci; 2013 Aug; 70(15):2677-96. PubMed ID: 23080209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
    Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
    Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.